These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
349 related articles for article (PubMed ID: 29789271)
1. Molecular elements in FGF19 and FGF21 defining KLB/FGFR activity and specificity. Agrawal A; Parlee S; Perez-Tilve D; Li P; Pan J; Mroz PA; Kruse Hansen AM; Andersen B; Finan B; Kharitonenkov A; DiMarchi RD Mol Metab; 2018 Jul; 13():45-55. PubMed ID: 29789271 [TBL] [Abstract][Full Text] [Related]
2. Differential specificity of endocrine FGF19 and FGF21 to FGFR1 and FGFR4 in complex with KLB. Yang C; Jin C; Li X; Wang F; McKeehan WL; Luo Y PLoS One; 2012; 7(3):e33870. PubMed ID: 22442730 [TBL] [Abstract][Full Text] [Related]
3. Tissue-specific expression of betaKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21. Kurosu H; Choi M; Ogawa Y; Dickson AS; Goetz R; Eliseenkova AV; Mohammadi M; Rosenblatt KP; Kliewer SA; Kuro-O M J Biol Chem; 2007 Sep; 282(37):26687-26695. PubMed ID: 17623664 [TBL] [Abstract][Full Text] [Related]
4. Identification of a crucial amino acid responsible for the loss of specifying FGFR1-KLB affinity of the iodinated FGF21. Luo W; Lin XM; Wang TX; Cai JL; Zeng XF; Zhu CR; Li RZ; Wang H; Wu XP J Cell Physiol; 2019 Mar; 234(3):2500-2510. PubMed ID: 30317562 [TBL] [Abstract][Full Text] [Related]
5. Optimization of Peptide Inhibitors of β-Klotho as Antagonists of Fibroblast Growth Factors 19 and 21. Pan J; Parlee SD; Brunel FM; Li P; Lu W; Perez-Tilve D; Liu F; Finan B; Kharitonenkov A; DiMarchi RD ACS Pharmacol Transl Sci; 2020 Oct; 3(5):978-986. PubMed ID: 33073195 [TBL] [Abstract][Full Text] [Related]
6. Fundamentals of FGF19 & FGF21 action in vitro and in vivo. Adams AC; Coskun T; Rovira AR; Schneider MA; Raches DW; Micanovic R; Bina HA; Dunbar JD; Kharitonenkov A PLoS One; 2012; 7(5):e38438. PubMed ID: 22675463 [TBL] [Abstract][Full Text] [Related]
7. A unique FGF23 with the ability to activate FGFR signaling through both αKlotho and βKlotho. Wu X; Weiszmann J; Ge H; Baribault H; Stevens J; Hawkins N; Vonderfecht S; Gardner J; Gupte J; Sheng J; Wang M; Li Y J Mol Biol; 2012 Apr; 418(1-2):82-9. PubMed ID: 22370560 [TBL] [Abstract][Full Text] [Related]
8. Biological and pharmacological functions of the FGF19- and FGF21-coreceptor beta klotho. Aaldijk AS; Verzijl CRC; Jonker JW; Struik D Front Endocrinol (Lausanne); 2023; 14():1150222. PubMed ID: 37260446 [TBL] [Abstract][Full Text] [Related]
9. Selective activation of FGFR4 by an FGF19 variant does not improve glucose metabolism in ob/ob mice. Wu X; Ge H; Lemon B; Weiszmann J; Gupte J; Hawkins N; Li X; Tang J; Lindberg R; Li Y Proc Natl Acad Sci U S A; 2009 Aug; 106(34):14379-84. PubMed ID: 19706524 [TBL] [Abstract][Full Text] [Related]
10. The breadth of FGF21's metabolic actions are governed by FGFR1 in adipose tissue. Adams AC; Yang C; Coskun T; Cheng CC; Gimeno RE; Luo Y; Kharitonenkov A Mol Metab; 2012; 2(1):31-7. PubMed ID: 24024127 [TBL] [Abstract][Full Text] [Related]
11. C-terminal tail of FGF19 determines its specificity toward Klotho co-receptors. Wu X; Lemon B; Li X; Gupte J; Weiszmann J; Stevens J; Hawkins N; Shen W; Lindberg R; Chen JL; Tian H; Li Y J Biol Chem; 2008 Nov; 283(48):33304-9. PubMed ID: 18829467 [TBL] [Abstract][Full Text] [Related]
12. Dynamics and Distribution of Klothoβ (KLB) and fibroblast growth factor receptor-1 (FGFR1) in living cells reveal the fibroblast growth factor-21 (FGF21)-induced receptor complex. Ming AY; Yoo E; Vorontsov EN; Altamentova SM; Kilkenny DM; Rocheleau JV J Biol Chem; 2012 Jun; 287(24):19997-20006. PubMed ID: 22523080 [TBL] [Abstract][Full Text] [Related]
13. The central fibroblast growth factor receptor/beta klotho system: Comprehensive mapping in Mus musculus and comparisons to nonhuman primate and human samples using an automated in situ hybridization platform. Hultman K; Scarlett JM; Baquero AF; Cornea A; Zhang Y; Salinas CBG; Brown J; Morton GJ; Whalen EJ; Grove KL; Koegler FH; Schwartz MW; Mercer AJ J Comp Neurol; 2019 Aug; 527(12):2069-2085. PubMed ID: 30809795 [TBL] [Abstract][Full Text] [Related]
14. Liver-specific activities of FGF19 require Klotho beta. Lin BC; Wang M; Blackmore C; Desnoyers LR J Biol Chem; 2007 Sep; 282(37):27277-27284. PubMed ID: 17627937 [TBL] [Abstract][Full Text] [Related]
15. Opposite alterations in FGF21 and FGF19 levels and disturbed expression of the receptor machinery for endocrine FGFs in obese patients. Gallego-Escuredo JM; Gómez-Ambrosi J; Catalan V; Domingo P; Giralt M; Frühbeck G; Villarroya F Int J Obes (Lond); 2015 Jan; 39(1):121-9. PubMed ID: 24813368 [TBL] [Abstract][Full Text] [Related]
17. Fibroblast growth factor 21, fibroblast growth factor receptor 1, and β-Klotho expression in bovine growth hormone transgenic and growth hormone receptor knockout mice. Brooks NE; Hjortebjerg R; Henry BE; List EO; Kopchick JJ; Berryman DE Growth Horm IGF Res; 2016; 30-31():22-30. PubMed ID: 27585733 [TBL] [Abstract][Full Text] [Related]
18. Different roles of N- and C- termini in the functional activity of FGF21. Micanovic R; Raches DW; Dunbar JD; Driver DA; Bina HA; Dickinson CD; Kharitonenkov A J Cell Physiol; 2009 May; 219(2):227-34. PubMed ID: 19117008 [TBL] [Abstract][Full Text] [Related]
19. The FGF21 Receptor Signaling Complex: Klothoβ, FGFR1c, and Other Regulatory Interactions. Kilkenny DM; Rocheleau JV Vitam Horm; 2016; 101():17-58. PubMed ID: 27125737 [TBL] [Abstract][Full Text] [Related]